Additionally, patients who were insulin-resistant or obese at baseline had improved cognitive outcomes following exenatide treatment [88]
A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection
Patient results vary based on starting weight, adherence, and individual health factors
Int J Obes Supplements 9(1):1019 Montenegro J, Armet AM, Willing BP, Deehan EC, Fassini PG, Mota JF, Walter J, Prado CM (2023) Exploring the influence of gut microbiome on energy metabolism in humans
Its rich content in monounsaturated fatty acids and PUFAs, as well as antioxidants, polyphenols, and dietary fibre, underlies its multi-targeted benefits, many of which may synergise with pharmacotherapies such as semaglutide to optimise clinical outcomes [112]